- Home
- BTG vs CORT Comparison
BTG vs CORT Comparison
Compare BTG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTG
- CORT
- Stock Information
- Founded
- BTG 2006
- CORT 1998
- Country
- BTG Canada
- CORT United States
- Employees
- BTG N/A
- CORT N/A
- Industry
- BTG Precious Metals
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- BTG Basic Materials
- CORT Health Care
- Exchange
- BTG Nasdaq
- CORT Nasdaq
- Market Cap
- BTG 4.2B
- CORT 4.0B
- IPO Year
- BTG N/A
- CORT N/A
- Fundamental
- Price
- BTG $2.68
- CORT $51.83
- Analyst Decision
- BTG Buy
- CORT Strong Buy
- Analyst Count
- BTG 3
- CORT 4
- Target Price
- BTG $4.12
- CORT $75.25
- AVG Volume (30 Days)
- BTG 14.5M
- CORT 1.2M
- Earning Date
- BTG 11-06-2024
- CORT 10-30-2024
- Dividend Yield
- BTG 5.97%
- CORT N/A
- EPS Growth
- BTG N/A
- CORT 57.97
- EPS
- BTG N/A
- CORT 1.26
- Revenue
- BTG $1,914,216,000.00
- CORT $628,555,000.00
- Revenue This Year
- BTG N/A
- CORT $46.29
- Revenue Next Year
- BTG $34.69
- CORT $17.09
- P/E Ratio
- BTG N/A
- CORT $41.11
- Revenue Growth
- BTG N/A
- CORT 39.67
- 52 Week Low
- BTG $2.34
- CORT $20.84
- 52 Week High
- BTG $3.50
- CORT $61.66
- Technical
- Relative Strength Index (RSI)
- BTG 25.09
- CORT 52.64
- Support Level
- BTG $2.66
- CORT $42.01
- Resistance Level
- BTG $3.44
- CORT $61.66
- Average True Range (ATR)
- BTG 0.12
- CORT 3.27
- MACD
- BTG -0.08
- CORT -0.03
- Stochastic Oscillator
- BTG 1.92
- CORT 49.97
About BTG B2Gold Corp Common shares (Canada)
B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other significant assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into a global market. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.